154 related articles for article (PubMed ID: 20827463)
1. Clozapine and other competitive antagonists reactivate risperidone-inactivated h5-HT7 receptors: radioligand binding and functional evidence for GPCR homodimer protomer interactions.
Teitler M; Toohey N; Knight JA; Klein MT; Smith C
Psychopharmacology (Berl); 2010 Dec; 212(4):687-97. PubMed ID: 20827463
[TBL] [Abstract][Full Text] [Related]
2. Risperidone-induced inactivation and clozapine-induced reactivation of rat cortical astrocyte 5-hydroxytryptamine₇ receptors: evidence for in situ G protein-coupled receptor homodimer protomer cross-talk.
Smith C; Toohey N; Knight JA; Klein MT; Teitler M
Mol Pharmacol; 2011 Feb; 79(2):318-25. PubMed ID: 21062995
[TBL] [Abstract][Full Text] [Related]
3. Human 5-HT7 receptor-induced inactivation of forskolin-stimulated adenylate cyclase by risperidone, 9-OH-risperidone and other "inactivating antagonists".
Toohey N; Klein MT; Knight J; Smith C; Teitler M
Mol Pharmacol; 2009 Sep; 76(3):552-9. PubMed ID: 19509219
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological analysis of the novel, rapid, and potent inactivation of the human 5-Hydroxytryptamine7 receptor by risperidone, 9-OH-Risperidone, and other inactivating antagonists.
Knight JA; Smith C; Toohey N; Klein MT; Teitler M
Mol Pharmacol; 2009 Feb; 75(2):374-80. PubMed ID: 18996971
[TBL] [Abstract][Full Text] [Related]
5. Decreased agonist, but not antagonist, binding to the naturally occurring Thr92Lys variant of the h5-HT7(a) receptor.
Brüss M; Kiel S; Bönisch H; Kostanian A; Göthert M
Neurochem Int; 2005 Aug; 47(3):196-203. PubMed ID: 15896881
[TBL] [Abstract][Full Text] [Related]
6. Risperidone irreversibly binds to and inactivates the h5-HT7 serotonin receptor.
Smith C; Rahman T; Toohey N; Mazurkiewicz J; Herrick-Davis K; Teitler M
Mol Pharmacol; 2006 Oct; 70(4):1264-70. PubMed ID: 16870886
[TBL] [Abstract][Full Text] [Related]
7. Antagonist interaction with the human 5-HT(7) receptor mediates the rapid and potent inhibition of non-G-protein-stimulated adenylate cyclase activity: a novel GPCR effect.
Klein MT; Teitler M
Br J Pharmacol; 2011 Apr; 162(8):1843-54. PubMed ID: 21198551
[TBL] [Abstract][Full Text] [Related]
8. Distinct electrophysiological effects of paliperidone and risperidone on the firing activity of rat serotonin and norepinephrine neurons.
Dremencov E; El Mansari M; Blier P
Psychopharmacology (Berl); 2007 Sep; 194(1):63-72. PubMed ID: 17530476
[TBL] [Abstract][Full Text] [Related]
9. How efficacious are 5-HT1B/D receptor ligands: an answer from GTP gamma S binding studies with stably transfected C6-glial cell lines.
Pauwels PJ; Tardif S; Palmier C; Wurch T; Colpaert FC
Neuropharmacology; 1997; 36(4-5):499-512. PubMed ID: 9225275
[TBL] [Abstract][Full Text] [Related]
10. Functional characterisation of the human cloned 5-HT7 receptor (long form); antagonist profile of SB-258719.
Thomas DR; Gittins SA; Collin LL; Middlemiss DN; Riley G; Hagan J; Gloger I; Ellis CE; Forbes IT; Brown AM
Br J Pharmacol; 1998 Jul; 124(6):1300-6. PubMed ID: 9720804
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological characterization of a serotonin receptor (5-HT7) stimulating cAMP production in human corneal epithelial cells.
Crider JY; Williams GW; Drace CD; Katoli P; Senchyna M; Sharif NA
Invest Ophthalmol Vis Sci; 2003 Nov; 44(11):4837-44. PubMed ID: 14578406
[TBL] [Abstract][Full Text] [Related]
12. Heterologous desensitization is evoked by both agonist and antagonist stimulation of the human 5-HT(7) serotonin receptor.
Krobert KA; Andressen KW; Levy FO
Eur J Pharmacol; 2006 Feb; 532(1-2):1-10. PubMed ID: 16487959
[TBL] [Abstract][Full Text] [Related]
13. Biochemical evidence that the atypical antipsychotic drugs clozapine and risperidone block 5-HT(2C) receptors in vivo.
Di Matteo V; Cacchio M; Di Giulio C; Di Giovanni G; Esposito E
Pharmacol Biochem Behav; 2002 Apr; 71(4):607-13. PubMed ID: 11888552
[TBL] [Abstract][Full Text] [Related]
14. Risperidone: a novel antipsychotic with balanced serotonin-dopamine antagonism, receptor occupancy profile, and pharmacologic activity.
Leysen JE; Janssen PM; Megens AA; Schotte A
J Clin Psychiatry; 1994 May; 55 Suppl():5-12. PubMed ID: 7520908
[TBL] [Abstract][Full Text] [Related]
15. 5-HT7 receptor-mediated relaxation of the oviduct in nonpregnant proestrus pigs.
Inoue M; Kitazawa T; Cao J; Taneike T
Eur J Pharmacol; 2003 Feb; 461(2-3):207-18. PubMed ID: 12586216
[TBL] [Abstract][Full Text] [Related]
16. [3H]-Mesulergine labels 5-HT7 sites in rat brain and guinea-pig ileum but not rat jejunum.
Hemedah M; Coupar IM; Mitchelson FJ
Br J Pharmacol; 1999 Jan; 126(1):179-88. PubMed ID: 10051134
[TBL] [Abstract][Full Text] [Related]
17. The human 5-HT7 serotonin receptor splice variants: constitutive activity and inverse agonist effects.
Krobert KA; Levy FO
Br J Pharmacol; 2002 Mar; 135(6):1563-71. PubMed ID: 11906971
[TBL] [Abstract][Full Text] [Related]
18. Differential inverse agonist efficacies of SB-258719, SB-258741 and SB-269970 at human recombinant serotonin 5-HT7 receptors.
Mahé C; Loetscher E; Feuerbach D; Müller W; Seiler MP; Schoeffter P
Eur J Pharmacol; 2004 Jul; 495(2-3):97-102. PubMed ID: 15249157
[TBL] [Abstract][Full Text] [Related]
19. Stimulation by antipsychotic agents of mitogen-activated protein kinase (MAPK) coupled to cloned, human (h)serotonin (5-HT)(1A) receptors.
Cussac D; Duqueyroix D; Newman-Tancredi A; Millan MJ
Psychopharmacology (Berl); 2002 Jul; 162(2):168-77. PubMed ID: 12110994
[TBL] [Abstract][Full Text] [Related]
20. The cloned human 5-HT7 receptor splice variants: a comparative characterization of their pharmacology, function and distribution.
Krobert KA; Bach T; Syversveen T; Kvingedal AM; Levy FO
Naunyn Schmiedebergs Arch Pharmacol; 2001 Jun; 363(6):620-32. PubMed ID: 11414657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
